J Arthroplasty:全关节置换早期乘飞机不增加DVT发生率

2014-07-04 紫川秀第二 丁香园

随着老年人口的增加,行关节置换的患者比例在急剧增多。已经有较多文献报道,关节置换术后患者较容易发生静脉血栓事件。而乘飞机需要较长时间的坐位制动,被认为有较高的血栓发生风险。 如果是全关节置换患者早期需要乘坐飞机进行长距离的转运,是否会增加患者出现血栓的风险呢,美国的纽约的学者就此有趣的问题进行了相关回顾性研究,结果发现,关节置换术后早期乘坐飞机并不会增加患者发生深静脉血栓事件的相关风险,相关

随着老年人口的增加,行关节置换的患者比例在急剧增多。已经有较多文献报道,关节置换术后患者较容易发生静脉血栓事件。而乘飞机需要较长时间的坐位制动,被认为有较高的血栓发生风险。

如果是全关节置换患者早期需要乘坐飞机进行长距离的转运,是否会增加患者出现血栓的风险呢,美国的纽约的学者就此有趣的问题进行了相关回顾性研究,结果发现,关节置换术后早期乘坐飞机并不会增加患者发生深静脉血栓事件的相关风险,相关文章发表在the journal of arthroscopy上。

研究共纳入1465例全关节置换术的患者,随访超过18月。术后对患者进行常规的DVT预防,包括早期活动,机械和药物预防。96%的患者术后接受阿司匹林作为单独的药物预防措施,而其余患者接受抗凝药物预防(表1)。

表1:患者接受抗凝治疗措施



上述患者中,共220例患者(15%)在全关节置换术后2.9天乘坐飞机(图1),而其余1245例患者未乘坐飞机,比较两组患者的人口统计学数据,并进行组间DVT发生率的比较。


图1:飞行距离


结果发现,乘飞机组患者出现症状性DVT,PE,VTE的数量分别为2例(0.9%),1例(0.5%)和3例(1.4%);而未乘飞机患者出现症状性DVT,PE,VTE的数量分别为5例(0.4%),10例(0.8%),15例(1.2%)。组间比较两组数据,无显著性差异。

研究者在讨论中分析,本研究是第一个报道飞行是否会增加关节置换术后静脉血栓发生率的文献报道,本研究证据强度较高的方面包括:入院研究的样本量较大;所有病例均来源一个治疗组;治疗入选患者未经特别筛选,保证了数据的全面性。

鉴于目前临床上并没有此类情况的指导性文件,作者推荐,参照本研究的结论,全关节置换术后的患者在进行规范化的抗凝治疗后可允许早期乘坐飞机进行短距离的飞行。

原始出处:

Cooper HJ1, Sanders SA2, Berger RA2.Risk of symptomatic venous thromboembolism associated with flying in the early postoperative period following elective total hip and knee arthroplasty.J Arthroplasty. 2014 Jun;29(6):1119-22. doi: 10.1016/j.arth.2014.01.005. Epub 2014 Jan 15.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1742295, encodeId=c4c41e42295a9, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Fri Jun 12 07:31:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826261, encodeId=4d8c182626103, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Nov 04 11:31:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649617, encodeId=f0fc164961eb6, content=<a href='/topic/show?id=49f9634e90' target=_blank style='color:#2F92EE;'>#DVT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6347, encryptionId=49f9634e90, topicName=DVT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af23885882, createdName=amy0558, createdTime=Mon Aug 18 04:31:00 CST 2014, time=2014-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710726, encodeId=776e1e107267f, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Thu Dec 25 11:31:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355882, encodeId=9ead1355882cd, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 06 00:31:00 CST 2014, time=2014-07-06, status=1, ipAttribution=)]
    2015-06-12 yxch48
  2. [GetPortalCommentsPageByObjectIdResponse(id=1742295, encodeId=c4c41e42295a9, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Fri Jun 12 07:31:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826261, encodeId=4d8c182626103, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Nov 04 11:31:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649617, encodeId=f0fc164961eb6, content=<a href='/topic/show?id=49f9634e90' target=_blank style='color:#2F92EE;'>#DVT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6347, encryptionId=49f9634e90, topicName=DVT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af23885882, createdName=amy0558, createdTime=Mon Aug 18 04:31:00 CST 2014, time=2014-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710726, encodeId=776e1e107267f, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Thu Dec 25 11:31:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355882, encodeId=9ead1355882cd, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 06 00:31:00 CST 2014, time=2014-07-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1742295, encodeId=c4c41e42295a9, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Fri Jun 12 07:31:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826261, encodeId=4d8c182626103, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Nov 04 11:31:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649617, encodeId=f0fc164961eb6, content=<a href='/topic/show?id=49f9634e90' target=_blank style='color:#2F92EE;'>#DVT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6347, encryptionId=49f9634e90, topicName=DVT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af23885882, createdName=amy0558, createdTime=Mon Aug 18 04:31:00 CST 2014, time=2014-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710726, encodeId=776e1e107267f, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Thu Dec 25 11:31:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355882, encodeId=9ead1355882cd, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 06 00:31:00 CST 2014, time=2014-07-06, status=1, ipAttribution=)]
    2014-08-18 amy0558
  4. [GetPortalCommentsPageByObjectIdResponse(id=1742295, encodeId=c4c41e42295a9, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Fri Jun 12 07:31:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826261, encodeId=4d8c182626103, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Nov 04 11:31:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649617, encodeId=f0fc164961eb6, content=<a href='/topic/show?id=49f9634e90' target=_blank style='color:#2F92EE;'>#DVT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6347, encryptionId=49f9634e90, topicName=DVT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af23885882, createdName=amy0558, createdTime=Mon Aug 18 04:31:00 CST 2014, time=2014-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710726, encodeId=776e1e107267f, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Thu Dec 25 11:31:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355882, encodeId=9ead1355882cd, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 06 00:31:00 CST 2014, time=2014-07-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1742295, encodeId=c4c41e42295a9, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Fri Jun 12 07:31:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826261, encodeId=4d8c182626103, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Tue Nov 04 11:31:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649617, encodeId=f0fc164961eb6, content=<a href='/topic/show?id=49f9634e90' target=_blank style='color:#2F92EE;'>#DVT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6347, encryptionId=49f9634e90, topicName=DVT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af23885882, createdName=amy0558, createdTime=Mon Aug 18 04:31:00 CST 2014, time=2014-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710726, encodeId=776e1e107267f, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Thu Dec 25 11:31:00 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355882, encodeId=9ead1355882cd, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jul 06 00:31:00 CST 2014, time=2014-07-06, status=1, ipAttribution=)]
    2014-07-06 zhaojie88

相关资讯

JOA:非骨水泥型假体一期翻修治疗假体感染

假体周围感染是关节置换术后的最严重并发症,给患者带来极大的痛苦,往往需要进行翻修手术。对于慢性假体周围感染,分期翻修手术是其治疗的金标准,据文献报道分期翻修手术的成功率在80%至95%之间。使用含抗生素的骨水泥一期置换翻修是治疗假体周围感染的另外一种选择,在特定的患者中具有较高的成功率(75%至90%)。 虽然使用不含抗生素的假体进行一期翻修的首次研究得到的临床结果并不满意,但是在某些时候使

BJJ:TKA术后非感染性伤口并发症影响临床疗效

现较多研究表明关节置换术后伤口并发症如渗出、不愈合、裂开等与术后关节深部感染发生有显著相关性,深部感染影响长期临床疗效同样较多文献报道,而非感染性伤口并发症是否影响术后疗效却鲜有报道。 为了明确需要再次返院处置的术后非感染性伤口并发症是否对术后关节置换疗效有影响,美国Adelani教授回顾性分析全膝置换后发生非感染性伤口并发症患者术后2年临床疗效,结果发表在近期BJJ上。【原文下载】

J Arthroplasty:TJA前无需常规进行牙齿的清洁准备

全关节置换术后的假体感染是灾难性的。最为常见的感染来源是手术过程中在切口内的细菌定植,其他如血源性等也可发生。考虑到假体感染后的灾难性后果,在术前做足预防措施并不为过。 牙齿疼痛是临床中较为常见的情形,通常这一症状可能预示着牙齿的感染,既往有研究认为,牙源性感染的高发生率对关节置换术是一个潜在的感染威胁,因此有医生要求,对择期关节置换的患者,最好在术前可以进行牙齿方面的清洁准备,但事实上

CORR:OA患者关节置换术后身体活动水平并无提高

老年骨性关节将导致患者关节疼痛和功能障碍,影响患者的日常及工作活动。全髋、全膝关节置换可以迅速缓解疼痛、改善肢体功能,提高生活质量。但是关节置换术后患者的的身体活动情况在术后能否得到提高却一直没有明确的研究。【原文下载】 针对上述问题,澳大利亚的Paula Harding D医生首次使用GT1M加速器对全髋全膝关节置换患者的身体活动情况进行了一项研究,发现骨性关节炎患者进行关节置换术后患者客

AAOS 2014:他汀类药物或可降低关节置换术后的血栓风险

长期以来,人们对他汀类药物的认识即为降低胆固醇药物,但最近,有研究发现,在非手术健康患者中,该类药物可减低深静脉血栓形成的发生风险。在3月11日的2014 美国骨外科学会(AAOS)年会上,研究者首次汇报了一项新研究,该研究显示,他汀类药物与常规血栓预防治疗联用可显著降低全关节置换(TJR)术后患者深静脉血栓形成(VTE)事件的发生风险,这项研究是相关领域进行的第一项研究。

BJJ:肥胖患者关节置换术前减肥危险更大

肥胖及相关合并疾病是导致关节炎的危险因素,晚期关节炎患者常常需要接受关节置换手术。肥胖患者不仅关节置换手术难度更大,手术时间更长,术后伤口感染等并发症的发生率也会增加,研究表明肥胖是导致关节置换患者术后再次入院的高风险因素,造成临床疗效不佳。 目前在临床上,医生会建议肥胖患者在进行关节置换手术前减肥,但是患者术前减肥以及减肥后维持体重是否会减少术后并发症发生率却无相关文献报道。因此美国加